| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.40B | 21.40B | 20.62B | 19.95B | 19.18B | 13.14B |
| Gross Profit | 14.32B | 14.32B | 14.04B | 13.72B | 12.03B | 7.86B |
| EBITDA | 5.17B | 6.53B | 6.53B | 6.53B | 4.85B | 3.22B |
| Net Income | 2.75B | 2.75B | 2.36B | 313.00M | 2.07B | 1.30B |
Balance Sheet | ||||||
| Total Assets | 41.01B | 41.01B | 42.68B | 40.89B | 39.99B | 35.36B |
| Cash, Cash Equivalents and Short-Term Investments | 16.77B | 16.77B | 19.49B | 18.34B | 16.51B | 13.43B |
| Total Debt | 13.15B | 13.15B | 16.36B | 15.67B | 15.05B | 13.59B |
| Total Liabilities | 18.84B | 18.84B | 22.05B | 21.87B | 20.12B | 17.48B |
| Stockholders Equity | 22.10B | 22.10B | 20.54B | 18.96B | 19.81B | 17.77B |
Cash Flow | ||||||
| Free Cash Flow | 3.40B | 3.26B | 3.67B | 3.51B | 3.76B | 2.71B |
| Operating Cash Flow | 4.44B | 4.44B | 4.70B | 4.49B | 4.64B | 3.22B |
| Investing Cash Flow | -1.55B | -1.55B | -2.56B | -2.07B | -2.28B | -2.19B |
| Financing Cash Flow | -2.55B | -2.55B | -1.82B | -2.32B | -1.77B | 906.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | CHF92.19B | 35.29 | ― | 1.94% | 2.80% | 11.97% | |
69 Neutral | CHF8.55B | 28.81 | ― | 2.70% | -13.19% | -88.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $8.55B | 141.35 | 0.49% | 2.73% | -13.19% | -88.43% |
At its 2025 Annual General Meeting in Geneva, Richemont’s shareholders approved all agenda items, including the appropriation of retained earnings and the payment of dividends on ‘A’ and ‘B’ shares. The meeting also saw the re-election of board members, the appointment of Wendy Luhabe as the ‘A’ shareholders’ representative, and the approval of KPMG SA as the new auditor. These decisions reflect Richemont’s commitment to maintaining strong governance and financial stability, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (CH:CFR) stock is a Buy with a CHF160.00 price target. To see the full list of analyst forecasts on Compagnie Financiere Richemont SA stock, see the CH:CFR Stock Forecast page.